Interleukin-1 inhibition and ischaemic stroke: has the time for a major outcomes trial arrived?

Eur Heart J. 2018 Oct 7;39(38):3518-3520. doi: 10.1093/eurheartj/ehy360.
No abstract available

Publication types

  • Comment

MeSH terms

  • Animals
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Brain Ischemia*
  • Interleukin-1
  • Mice
  • Stroke*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Interleukin-1
  • canakinumab